Volume 22, Number 6—June 2016
Dispatch
Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009–2014
Felix C. Ringshausen
, Dirk Wagner, Andrés de Roux, Roland Diel, David Hohmann, Lennart Hickstein, Tobias Welte, and Jessica Rademacher
, Dirk Wagner, Andrés de Roux, Roland Diel, David Hohmann, Lennart Hickstein, Tobias Welte, and Jessica Rademacher
Table 2
Most common and relevant comorbidities among case-patients with nontuberculous mycobacterial pulmonary disease, Germany, 2009–2014*
| ICD-10 codes | Diagnosis | No. (%) patients |
|||||
|---|---|---|---|---|---|---|---|
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | ||
| A31.0 |
NTM-PD |
85 |
96 |
106 |
106 |
104 |
126 |
| J43–44 | COPD and emphysema | 53 (62.4) | 67 (69.8) | 84 (79.2) | 67 (63.2) | 76 (73.1) | 87 (69.0) |
| J40–42 | Chronic or unspecified bronchitis | 24 (28.2) | 26 (27.1) | 34 (32.1) | 28 (26.4) | 44 (42.3) | 41 (32.5) |
| E10–11 | Diabetes mellitus, type 1 and type 2 | 45 (52.9) | 28 (29.2) | 15 (14.2) | 20 (18.9) | 21 (20.2) | 28 (22.2) |
| J09–18 | Influenza and pneumonia | 21 (24.7) | 17 (17.7) | 28 (26.4) | 24 (22.6) | 35 (33.7) | 29 (23.0) |
| M80–81 | Osteoporosis | 18 (21.2) | 20 (20.8) | 27 (25.5) | 23 (21.7) | 23 (22.1) | 26 (20.6) |
| J45 | Asthma | 18 (21.2) | 25 (26.0) | 31 (29.2) | 22 (20.8) | 23 (22.1) | 34 (27.0) |
| J96 | Respiratory failure | 16 (18.8) | 21 (21.9) | 25 (23.6) | 20 (18.9) | 23 (22.1) | 33 (26.2) |
| J20–22 | Acute bronchitis and bronchiolitis | 8 (9.4) | 17 (17.7) | 17 (16.0) | 27 (25.5) | 18 (17.3) | 26 (20.6) |
| A15–19 | Tuberculosis | 12 (14.1) | 14 (14.6) | 16 (15.1) | 21 (19.8) | 25 (24.0) | 17 (13.5) |
| F17 | Tobacco use | 13 (15.3) | 17 (17.7) | 17 (16.0) | 16 (15.1) | 14 (13.5) | 16 (12.7) |
| K21 | Gastro-esophageal reflux disease | 13 (15.3) | 15 (15.6) | 18 (17.0) | 14 (13.2) | 17 (16.3) | 20 (15.9) |
| J47 | Bronchiectasis | 6 (7.1) | 9 (9.4) | 9 (8.5) | 7 (6.6) | 16 (15.4) | 23 (18.3) |
| C34 | Lung cancer | 3 (3.5) | 4 (4.2) | 7 (6.6) | 9 (8.5) | 5 (4.8) | 13 (10.3) |
| M05–06 | Rheumatoid arthritis | 3 (3.5) | 11 (11.5) | 8 (7.5) | 4 (3.8) | 2 (1.9) | 9 (7.1) |
| B20–24 | Human immunodeficiency virus | 1 (1.2) | 2 (2.1) | 5 (4.7) | 4 (3.8) | 5 (4.8) | 5 (4.0) |
| D90 | Immunosuppression | 0 | 1 (1.0) | 2 (1.9) | 1 (0.9) | 2 (1.9) | 1 (0.8) |
| Z94 | Transplant organ and tissue status | 1 (1.2) | 1 (1.0) | 1 (0.9) | 0 | 2 (1.9) | 2 (1.6) |
| E84 | Cystic fibrosis | 0 | 1 (1.0) | 0 | 0 | 2 (1.9) | 2 (1.6) |
*ICD-10, International Classification of Diseases, 10th revision; NTM-PD, nontuberculous mycobacterial pulmonary disease; COPD, chronic obstructive pulmonary disease.
Page created: May 16, 2016
Page updated: May 16, 2016
Page reviewed: May 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.